Organigram (US:OGI)2026-02-10 14:00Financial Data and Key Metrics Changes - In Q1, net revenue increased by 49% to CAD 65.3 million from CAD 42.7 million in the same prior year period, primarily due to growth in the Canadian business, the integration of Motif, and higher international sales [16] - Adjusted gross profit for the quarter increased by 67% to CAD 23.9 million compared to CAD 14.3 million in Q1 last year, supported by higher yields and lower cultivation costs [16][17] - Adjusted EBITDA in Q1 was CAD 5.3 million, up 273% from CAD 1.4 million in the prior year period [19] - Net income for the quarter was CAD 20 million compared to a net loss of CAD 23 million in the same prior year period [19] Business Line Data and Key Metrics Changes - International sales for Q1 were CAD 5 million, up 51% over Q1 last year, despite a sequential decline due to higher-than-expected out-of-spec flower [16][12] - The company maintained the number one position in overall vapes with a 20.4% market share and moved to the number two position in overall pre-rolls at 7.7% [7][6] - In beverages, market share increased by 80 basis points year-over-year to 5.9%, while in concentrates, the company achieved a 15.5% category share [8][7] Market Data and Key Metrics Changes - In Canada, the company held the number one market share position with 11.3% total share in Q1 and 11.7% over the past 12 months [5] - Market share in Quebec improved to the number three position with 9.9% for the quarter, driven by successful vape launches [6] - The company outperformed in several provinces, holding 33.1% market share in New Brunswick and 21.9% in Newfoundland [7] Company Strategy and Development Direction - The company aims to focus on operational execution, cost base improvement, and margin enhancement in the short term, while pursuing international expansion in the long term [28] - The company is optimistic about the long-term growth of the cannabis industry and its ability to compete and lead as growth continues [5] - New product innovations, including SHRED Soda and SHRED Shots, are expected to enhance market competitiveness [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the impact of the BC labor strike and increased competition in vapes and pre-rolls but expressed confidence in recovering sales and maintaining adjusted gross margins [15][19] - The company is addressing temporary issues with international flower specifications and expects to return to normal operating parameters [12][34] - Management remains confident in delivering against full-year guidance of revenue exceeding CAD 300 million, supported by improving fundamentals and expanding margins [23] Other Important Information - The company harvested over 28,000 kilograms of flower in Q1, representing a 43% year-over-year increase [10] - The company is in the final phases of ERP implementation, with expectations for associated costs to roll off after the second quarter [18] - The company is preparing for EU GMP certification and is working closely with regulators to address feedback received [46] Q&A Session Summary Question: Near-term opportunities and long-term initiatives - Management emphasized the focus on operational execution and cost base improvement in the short term, while balancing future growth opportunities in international markets [27][28] Question: Insights on international volumes and flower issues - Management noted that stringent international flower requirements led to temporary issues, with an estimated CAD 3.5 million impact on international revenue [34][35] Question: Recovery in the Canadian market - Management confirmed that sales in BC have returned to traditional distribution levels and expressed confidence in addressing increased competition with new product launches [41][42] Question: EU GMP certification timeline - Management stated that they are working closely with regulators to resolve questions and are aiming for the fastest timeline possible, though no specific date can be provided [46] Question: Route to market in Europe - Management indicated a mixed approach for market entry, utilizing both direct sales and partnerships depending on regulations and market conditions [50][51] Question: U.S. market strategy and regulatory environment - Management highlighted that the U.S. market is currently a minor part of the business and emphasized a cautious approach to investment until regulatory clarity is achieved [54][55]